Effects and mechanism of STAT3 silencing on the growth and apoptosis of colorectal cancer cells

Li,Jing; Liu,You‑Yu; Yang,Xue‑Feng; Shen,Dao‑Fu; Sun,Hong‑Zhi; Huang,Ke‑Qiang; Zheng,Hua‑Chuan

doi:10.3892/ol.2018.9368

Effects and mechanism of STAT3 silencing on the growth and apoptosis of colorectal cancer cells

Authors:
- Jing Li
- You‑Yu Liu
- Xue‑Feng Yang
- Dao‑Fu Shen
- Hong‑Zhi Sun
- Ke‑Qiang Huang
- Hua‑Chuan Zheng
View Affiliations

Affiliations: Department of Gastroenterology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China, Department of Orthopedics, The Central Hospital of Liaoyang, Liaoyang, Liaoning 111000, P.R. China, Tumor Basic and Translational Laboratory, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China, Department of Orthodontics, School of Stomatology, Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China
Published online on: August 29, 2018 https://doi.org/10.3892/ol.2018.9368
Pages: 5575-5582
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Signal transducer and activator of transcription 3 (STAT3) have roles in various cellular processes, including angiogenesis, apoptosis, cell cycle progression, cell migration and drug resistance. To clarify the effects of STAT3 in colorectal cancer (CRC) cells and the underlying molecular mechanisms, STAT3 was directly silenced, and the effects of STAT3 silencing on cell proliferation, apoptosis and growth with phenotype‑associated molecules were examined.pSH1‑Si‑STAT3 was successfully transfected into the CRC HCT‑116 and SW480 cell lines, which was verified by GFP tagging under a fluorescence microscope. An MTT assay revealed that the proliferation of both cell lines that were transfected with pSH1‑Si‑STAT3 was significantly suppressed in comparison with the control and mock (P<0.05). Acridine orange/ethidium bromide staining and flow cytometry indicated that the transfected cell lines had a significantly higher rate of apoptosis than the control‑ and mock‑treated cells (P<0.05). STAT3‑silienced cells were also significantly arrested at the G2/M stage compared with the cells that were transfected with control and mock plasmids (P<0.05). At the mRNA level, the expression of STAT3 and survivin was significantly downregulated (P<0.05), but p53 and caspase‑3 were significantly upregulated (P<0.05). The significantly different patterns of expression were observed in western blot analysis (P<0.05). The findings of the present study indicate that STAT3 silencing may suppress the proliferation and growth of CRC cells, and induce their apoptosis by upregulating the expression of survivin, p53 and caspase‑3. Therefore, STAT3 may be a good candidate for CRC gene therapy.

View Figures

View References

1	Wake MS and Watson CJ: STAT3 the oncogene-still eluding therapy? FEBS J. 282:2600–2611. 2015. View Article : Google Scholar : PubMed/NCBI
2	Zhao C, Li H, Lin HJ, Yang S, Lin J and Liang G: Feedback activation of STAT3 as a cancer drug-resistance mechanism. Trends Pharmacol Sci. 37:47–61. 2016. View Article : Google Scholar : PubMed/NCBI
3	Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell JE Jr: Stat3 as an oncogene. Cell. 98:295–303. 1999. View Article : Google Scholar : PubMed/NCBI
4	Srivastava J and DiGiovanni J: Non-canonical Stat3 signaling in cancer. Mol Carcinog. 55:1889–1898. 2016. View Article : Google Scholar : PubMed/NCBI
5	You L, Wang Z, Li H, Shou J, Jing Z, Xie J, Sui X, Pan H and Han W: The role of STAT3 in autophagy. Autophagy. 11:729–739. 2015. View Article : Google Scholar : PubMed/NCBI
6	Yu H, Lee H, Herrmann A, Buettner R and Jove R: Revisiting STAT3 signaling in cancer: New and unexpected biological functions. Nat Rev Cancer. 14:736–746. 2014. View Article : Google Scholar : PubMed/NCBI
7	Carbognin E, Betto RM, Soriano ME, Smith AG and Martello G: Stat3 promotes mitochondrial transcription and oxidative respiration during maintenance and induction of naive pluripotency. EMBO J. 35:618–634. 2016. View Article : Google Scholar : PubMed/NCBI
8	Erlich TH, Yagil Z, Kay G, Peretz A, Migalovich-Sheikhet H, Tshori S, Nechushtan H, Levi-Schaffer F, Saada A and Razin E: Mitochondrial STAT3 plays a major role in IgE-antigen-mediated mast cell exocytosis. J Allergy Clin Immunol. 134:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
9	Park JK, Hong R, Kim KJ, Lee TB and Lim SC: Significance of p-STAT3 expression in human colorectal adenocarcinoma. Oncol Rep. 20:597–604. 2008.PubMed/NCBI
10	Ferguson SD, Srinivasan VM and Heimberger AB: The role of STAT3 in tumor-mediated immune suppression. J Neurooncol. 123:385–394. 2015. View Article : Google Scholar : PubMed/NCBI
11	Furtek SL, Backos DS, Matheson CJ and Reigan P: Strategies and approaches of targeting STAT3 for cancer treatment. ACS Chem Biol. 11:308–318. 2016. View Article : Google Scholar : PubMed/NCBI
12	Chai EZ, Shanmugam MK, Arfuso F, Dharmarajan A, Wang C, Kumar AP, Samy RP, Lim LH, Wang L, Goh BC, et al: Targeting transcription factor STAT3 for cancer prevention and therapy. Pharmacol Ther. 162:86–97. 2016. View Article : Google Scholar : PubMed/NCBI
13	Zhao Y, Chen S, Gou WF, Niu ZF, Zhao S, Xiao LJ, Takano Y and Zheng HC: The role of EMMPRIN expression in ovarian epithelial carcinomas. Cell Cycle. 12:2899–2913. 2013. View Article : Google Scholar : PubMed/NCBI
14	Lassmann S, Schuster I, Walch A, Göbel H, Jütting U, Makowiec F, Hopt U and Werner M: STAT3 mRNA and protein expression in colorectal cancer: Effects on STAT3-inducible targets linked to cell survival and proliferation. J Clin Pathol. 60:173–179. 2007. View Article : Google Scholar : PubMed/NCBI
15	Ma XT, Wang S, Ye YJ, Du RY, Cui ZR and Somsouk M: Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma. World J Gastroentero. 10:1569–1573. 2004. View Article : Google Scholar
16	Xue X, Jungles K, Onder G, Samhoun J, Győrffy B and Hardiman KM: HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling. Oncotarget. 7:11567–11579. 2016. View Article : Google Scholar : PubMed/NCBI
17	Zou F, Mao R, Yang L, Lin S, Lei K, Zheng Y, Ding Y, Zhang P, Cai G, Liang X and Liu J: Targeted deletion of miR-139-5p activates MAPK, NF-κB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer. FEBS J. 283:1438–1452. 2016. View Article : Google Scholar : PubMed/NCBI
18	Yao C, Su L, Shan J, Zhu C, Liu L, Liu C, Xu Y, Yang Z, Bian X, Shao J, et al: IGF/STAT3/NANOG/Slug signaling axis simultaneously controls epithelial-mesenchymal transition and stemness maintenance in colorectal cancer. Stem Cells. 34:820–831. 2016. View Article : Google Scholar : PubMed/NCBI
19	Liu H, Ren G, Wang T, Chen Y, Gong C, Bai Y, Wang B, Qi H, Shen J, Zhu L, et al: Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition. Carcinogenesis. 36:459–468. 2015. View Article : Google Scholar : PubMed/NCBI
20	Spitzner M, Roesler B, Bielfeld C, Emons G, Gaedcke J, Wolff HA, Rave-Fränk M, Kramer F, Beissbarth T, Kitz J, et al: STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo. Int J Cancer. 134:997–1007. 2014. View Article : Google Scholar : PubMed/NCBI
21	Fan LC, Teng HW, Shiau CW, Tai WT, Hung MH, Yang SH, Jiang JK and Chen KF: Pharmacological targeting SHP-1-STAT3 signaling is a promising therapeutic approach for the treatment of colorectal cancer. Neoplasia. 17:687–696. 2015. View Article : Google Scholar : PubMed/NCBI
22	Xiong H, Chen ZF, Liang QC, Du W, Chen HM, Su WY, Chen GQ, Han ZG and Fang JY: Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling. J Cell Mol Med. 13:3668–3679. 2009. View Article : Google Scholar : PubMed/NCBI
23	Zhao B and Dong AS: MiR-874 inhibits cell growth and induces apoptosis by targeting STAT3 in human colorectal cancer cells. Eur Rev Med Pharmacol Sci. 20:269–277. 2016.PubMed/NCBI
24	Zhang J, Lu Y, Yue X, Li H, Luo X, Wang Y, Wang K and Wan J: MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3. PLoS One. 8:e703002013. View Article : Google Scholar : PubMed/NCBI
25	Liu F, Zhang T, Zou S, Jiang B and Hua D: B7-H3 promotes cell migration andinvasion through the Jak2/Stat3/MMP9 signaling pathway in colorectal cancer. Mol Med Rep. 12:5455–5460. 2015. View Article : Google Scholar : PubMed/NCBI
26	Zhang T, Jiang B, Zou ST, Liu F and Hua D: Overexpression of B7-H3 augmentsanti-apoptosis of colorectal cancer cells by Jak2-STAT3. World J Gastroenterol. 21:1804–1813. 2015. View Article : Google Scholar : PubMed/NCBI
27	Wei X, Wang G, Li W, Hu X, Huang Q, Xu K, Lou W, Wu J, Liang C, Lou Q, et al: Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells. Oncol Rep. 31:335–341. 2014. View Article : Google Scholar : PubMed/NCBI
28	Qian WF, Guan WX, Gao Y, Tan JF, Qiao ZM, Huang H and Xia CL: Inhibition of STAT3 by RNA interference suppresses angiogenesis in colorectal carcinoma. Braz J Med Biol Res. 44:1222–1230. 2011. View Article : Google Scholar : PubMed/NCBI
29	Cascio S, Ferla R, D'Andrea A, Gerbino A, Bazan V, Surmacz E and Russo A: Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells. J Cell Physiol. 221:189–194. 2009. View Article : Google Scholar : PubMed/NCBI
30	Soleimanpour E and Babaei E: Survivin as a potential target for cancer therapy. Asian Pac J Cancer Prev. 16:6187–6191. 2015. View Article : Google Scholar : PubMed/NCBI
31	Xiao LJ, Zhao S, Zhao EH, Zheng X, Gou WF, Takano Y and Zheng HC: Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas. Oncol Lett. 6:1277–1284. 2013. View Article : Google Scholar : PubMed/NCBI
32	Wang X, Simpson ER and Brown KA: p53: Protection against tumor growth beyond effects on cell cycle and apoptosis. Cancer Res. 75:5001–5007. 2015. View Article : Google Scholar : PubMed/NCBI